☰

Xiaoxia Ye, Ph.D. - Publications

Affiliations: 
2012 Chemistry University of Alberta, Edmonton, Alberta, Canada 
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gupta N, Gopal K, Wu C, Alshareef A, Chow A, Wu F, Wang P, Ye X, Bigras G, Lai R. Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers. 10. PMID 29401647 DOI: 10.3390/Cancers10020041  0.357
2015 Ren X, Shi Y, Zhao D, Xu M, Li X, Dang Y, Ye X. Naringin protects ultraviolet B-induced skin damage by regulating p38 MAPK signal pathway. Journal of Dermatological Science. PMID 26908354 DOI: 10.1016/j.jdermsci.2015.12.008  0.345
2015 Alqahtani H, Gopal K, Gupta N, Jung K, Alshareef A, Ye X, Wu F, Li L, Lai R. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer. Cellular Signalling. PMID 26569340 DOI: 10.1016/J.Cellsig.2015.11.004  0.413
2015 Jung K, Gupta N, Wang P, Lewis JT, Gopal K, Wu F, Ye X, Alshareef A, Abdulkarim BS, Douglas DN, Kneteman NM, Lai R. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter. Oncotarget. 6: 10366-73. PMID 25868977 DOI: 10.18632/Oncotarget.3590  0.336
2014 Jung K, Wang P, Gupta N, Gopal K, Wu F, Ye X, Alshareef A, Bigras G, McMullen TP, Abdulkarim BS, Lai R. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays. Breast Cancer Research : Bcr. 16: 470. PMID 25380620 DOI: 10.1186/S13058-014-0470-2  0.351
2014 Jung K, Wu F, Wang P, Ye X, Abdulkarim BS, Lai R. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells. Bmc Cancer. 14: 328. PMID 24885403 DOI: 10.1186/1471-2407-14-328  0.33
2014 Ye X, Wu F, Wu C, Wang P, Jung K, Gopal K, Ma Y, Li L, Lai R. β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells Cellular Signalling. 26: 492-501. PMID 24291232 DOI: 10.1016/J.Cellsig.2013.11.023  0.412
2013 Wu F, Ye X, Wang P, Jung K, Wu C, Douglas D, Kneteman N, Bigras G, Ma Y, Lai R. Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity. Bmc Cancer. 13: 317. PMID 23815808 DOI: 10.1186/1471-2407-13-317  0.329
2012 Wu F, Zhang J, Wang P, Ye X, Jung K, Bone KM, Pearson JD, Ingham RJ, McMullen TP, Ma Y, Lai R. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. Cellular Signalling. 24: 1989-98. PMID 22800865 DOI: 10.1016/J.Cellsig.2012.07.008  0.366
2012 Wang P, Zhang JD, Wu F, Ye X, Sharon D, Hitt M, McMullen TP, Hegazy SA, Gelebart P, Yang J, Ma Y, Lai R. The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma. Cellular Signalling. 24: 1955-63. PMID 22743134 DOI: 10.1016/J.Cellsig.2012.06.005  0.338
Show low-probability matches.